Evolution in the indications for anti-viral therapy in chronic hepatitis B
Jinjin LIU; Mengyang ZHANG; Yameng SUN; Hong YOU.
Journal of Clinical Hepatology
; (12): 1299-1303, 2023.
ArtÃculo en Zh | WPRIM | ID: wpr-978782
Documentos relacionados
Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses.
Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline.
[Different treatment strategies in patients with HBeAg-positive and negative chronic hepatitis B].
Prognosis of acute-on-chronic liver failure caused by hepatitis recurrence after withdrawal of nucleos(t)ide analogues in chronic hepatitis B patients with different HBeAg status
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients.
Assessment of chronic hepatitis B: the importance of hepatitis B virus DNA testing.
Diagnosis and treatment of chronic hepatitis B: 2009 update.
Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B.
Characterization of BCP/PreC/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing.